Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes

• Hlavní autoři: Savchenko Liudmyla G. (Autor), Digtiar Nataliia I. (Autor), Selikhova Liudmyla G. (Autor), Kaidasheva Elvira I. (Autor), Shlykova Oksana A. (Autor), Vesnina Liudmyla E. (Autor), Kaidashev Igor P. (Autor)
• Médium: Kniha
• Vydáno: Sciendo, 2019-09-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Introduction. Liraglutide (L) is the analogue of human glucagon-like peptide 1 which stimulates glucose-dependent insulin secretion and can modify the level of inflammatory biomarkers.